Kawasaki, Japan

Kazuyuki Ubukata

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyuki Ubukata. Retrieved from https://idiyas.com/inventor/kazuyuki-ubukata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 20.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuyuki Ubukata: Innovator in Therapeutic Agents

Introduction

Kazuyuki Ubukata is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of therapeutic agents, particularly through his work on phenylalanine derivatives. With a total of two patents to his name, Ubukata's innovations are aimed at addressing various diseases related to α4 integrin.

Latest Patents

Ubukata's latest patents focus on specific phenylalanine derivatives and analogues that exhibit antagonistic activity to α4 integrin. These compounds are being developed as therapeutic agents for a range of diseases associated with this integrin. His work in this area highlights the potential for these derivatives to play a crucial role in medical treatments.

Career Highlights

Kazuyuki Ubukata is currently employed at Ajinomoto Co., Ltd., where he continues to advance his research and development efforts. His expertise in the field has positioned him as a key figure in the innovation of therapeutic solutions.

Collaborations

Ubukata has collaborated with notable colleagues, including Kazuyuki Sagi and Tatsuya Okuzumi. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kazuyuki Ubukata's work in the field of therapeutic agents demonstrates his commitment to innovation and medical advancement. His contributions through patents and collaborations are paving the way for new treatments in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…